Evidence map›Paper›PMID 39994359›Full record

ArticleCommunications medicine2025

Influence of the Covid-19 pandemic on cerebrovascular diseases in the Sao Paulo region of Brazil.

Raiene Telassin Abbas-Kayano, Yara Hahr Marques Hökerberg, Raquel de Vasconcellos Carvalhaes de Oliveira

Abstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Raiene Telassin Abbas-KayanoFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI), Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-2566-6426
Yara Hahr Marques HökerbergFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI), Rio de Janeiro, Brazil.
Raquel de Vasconcellos Carvalhaes de OliveiraFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI), Rio de Janeiro, Brazil. raquel.vasconcellos@ini.fiocruz.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rapid spread of covid-19 overwhelmed healthcare systems. This study aimed to investigate the impact of the covid-19 pandemic on hospitalizations and hospital deaths due to cerebrovascular diseases (CVD) in São Paulo state, Brazil.

methodsThis ecologic study evaluated the CVD hospitalizations and hospital deaths (2017-2021) by demographic features and CVD type. During the pandemic (2020-2021), segmented regression models were used to detect changes in CVD trends. We also evaluated the detrended cross-correlation between CVD deaths and hospitalization with the SARS-Cov-2 infection series.

resultsDuring the pandemic, there is a 35% reduction in CVD hospitalizations, mainly in elective admissions and ischemic stroke, but a 6.5% increase in deaths, especially in Black and Brown individuals, and those aged 20-29 years. From 2020 to 2021, Black and Brown individuals experience an earlier and more prolonged increase in hospital deaths. Ischemic CVD hospitalizations decrease in the first quarter of 2020. Older people exhibit a monthly increase of 2.9% in hospitalizations and 5.3% in deaths in the 2nd and 3rd quarters of 2021. SARS-Cov-2 infections are inversely correlated to CVD hospitalizations and directly correlated to CVD hospital deaths.

conclusionsCovid-19 pandemic negatively affects CVD hospitalizations and deaths, particularly in Black and Brown individuals. The decrease in hospitalizations and increase in hospital deaths of ischemic CVD highlights vulnerability in accessing healthcare resources during the pandemic.

Identifiers

PMID39994359
PMCPMC11850832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.